AMPIO PHARMACEUTICALS, INC. EXTENTION AGREEMENT FOR NOTES PAYABLE TOTAL PRINCIPAL AMOUNT: $100,000Extension Agreement for Notes Payable • February 15th, 2011 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations
On August 10, 2010, the undersigned Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Maker”), issued one promissory note (the “Note”) in the amount of $100,000.00, and promised to pay to the order of James Ludvik, and his successors or assigns (collectively, the “Holder”), the aggregate sum of $100,000.00 due under the Note, together with interest at the rate of 8.0% (eight percent) per annum until the Note is paid in full. The Note was originally due on January 31, 2011.
AMPIO PHARMACEUTICALS, INC. EXTENTION AGREEMENT FOR NOTES PAYABLE TOTAL PRINCIPAL AMOUNT: $100,000Extension Agreement for Notes Payable • February 15th, 2011 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations
On August 10, 2010, the undersigned Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Maker”), issued one promissory note (the “Note”) in the amount of $100,000.00, and promised to pay to the order of Richard B. Giles, and his successors or assigns (collectively, the “Holder”), the aggregate sum of $100,000.00 due under the Note, together with interest at the rate of 8.0% (eight percent) per annum until the Note is paid in full. The Note was originally due on January 31, 2011.
EXTENSION AGREEMENT FOR NOTES PAYABLE TOTAL PRINCIPAL AMOUNT: $100,000Extension Agreement for Notes Payable • May 17th, 2010 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations
On November 12, 2009 and December 4, 2009, the undersigned, DMI Life Sciences, Inc., a Delaware corporation following its reincorporation in March 2010 (“Maker”) issued two promissory notes, each in the principal amount of $50,000 (the “Notes”) and promised to pay to the order of Michael Macaluso, together with any successors or assigns (collectively, the “Holder”), the aggregate principal sum of One Hundred Thousand United States Dollars (US $100,000), with interest accruing on the outstanding principal amount of the Notes at an annual rate of six percent (6.0%) until the Notes are paid in full. The Notes had original due dates of April 30, 2010.
EXTENSION AGREEMENT FOR NOTES PAYABLE TOTAL PRINCIPAL AMOUNT: $100,000Extension Agreement for Notes Payable • May 17th, 2010 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations
On November 6, 2009 and November 20, 2009, the undersigned, DMI Life Sciences, Inc., a Delaware corporation following its reincorporation in March 2010 (“Maker”) issued two promissory notes, each in the principal amount of $50,000 (the “Notes”) and promised to pay to the order of DMI BioSciences, Inc., together with any successors or assigns (collectively, the “Holder”), the aggregate principal sum of One Hundred Thousand United States Dollars (US $100,000), with interest accruing on the outstanding principal amount of the Notes at an annual rate of six percent (6.0%) until the Notes are paid in full. The Notes had original due dates of April 30, 2010.
AMPIO PHARMACEUTICALS, INC. EXTENTION AGREEMENT FOR NOTES PAYABLE TOTAL PRINCIPAL AMOUNT: $230,000Extension Agreement for Notes Payable • February 15th, 2011 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations
On August 12, 2010 and August 16, 2010, the undersigned Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Maker”), issued two promissory notes (the “Notes”) in the amounts of $30,000.00 and $200,000.00, respectively, and promised to pay to the order of Michael Macaluso, and his successors or assigns (collectively, the “Holder”), the aggregate sum of $230,000.00 due under the Notes, together with interest at the rate of 8.0% (eight percent) per annum until the Notes are paid in full. The Notes were originally due on January 31, 2011.
